Panacea Biotec Ltd Share Price

Q: What is the share price of Panacea Biotec Ltd today?

Panacea Biotec Ltd share price as on 31 Jan 2025 is ₹341.6

Biotechnology

NSE: PANACEABIO Small Cap ISIN: INE922B01023

As on 31 January 2025 at 13:59 IST

₹341.60

+ 16.25

(4.99%)

Sell Buy

Over 1 Month

-22.23%

Over 6 Months

131.63%

Over 1 Year

98.93%

Over 3 Years

35.37%

Panacea Biotec Ltd Summary

Close ₹ 341.60

Open ₹ 329

High ₹ 341.60

Low ₹ 322.25

Volume 3,87,365

Net Turnover (in ₹ Cr) ₹ 9.71

52Wk High ₹ 490.55

52Wk Low ₹ 112.35

52Wk High / Low

112.35

490.55

Panacea Biotec Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,992.79

EPS (TTM) -

Book Value (BV) 51.69

Div. Yield -

P/E (TTM) -148.36

Price/Book Value 6.29

Delivery % 47.78 %

Face Value 1

Key Ratios

PE Ratio 209.14

PB Ratio 2.42

EV to Sales 2.31

PEG Ratio -2.01

ROA 0.74

ROE 0.86

Debt-Equity 0.32

Net Profit Margin 0.99

Operating Profit Margin 10.86

Panacea Biotec Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	584.96	511.61	672.20	634.78	573.75
Total Expenses	619.52	601.47	899.05	779.11	729.90
Profit Before Tax	1.48	12.80	1,449.36	-144.25	-171.22
Profit After Tax	-1.50	-33.74	1,078.33	-146.20	-187.86
Operating Profit after Depreciation	-30.98	-85.42	-46.01	41.01	17.83

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	596.04	614.27	634.42	621.87	671.89
Total Non Current Assets	755.49	708.85	808.31	666.56	707.03
Total Current Assets	485.18	562.32	950.55	510.97	683.27
TOTAL ASSETS	1,240.67	1,271.17	1,758.87	1,177.53	1,390.30
Total Shareholder's Fund	842.05	843.60	876.64	-228.69	198.79

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	-0.10	-422.45	-108.45	106.76	-30.47
Net Cash used in Investing Activities	10.23	430.33	1,282.56	-47.79	-34.52
Net Cash used in Financing Activities	-2.81	-18.37	-1,175.85	-47.11	90.74

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	384.51	291.50	248.07	364.30	188.96
Total Expenses	380.31	354.25	341.65	377.16	252.49
Profit Before Tax	4.21	-62.75	-93.58	-12.85	-78.92
Profit After Tax	3.55	-87.54	-93.58	-14.41	-96.02
Operating Profit after Depreciation	17.99	-52.69	-86.53	-5.33	-58.26

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	383	396.74	416.15	398.48	447.37
Total Non Current Assets	570.44	524.77	513.01	497.74	524.17
Total Current Assets	183.20	199.13	248.83	292.55	614.32
TOTAL ASSETS	753.64	723.90	761.83	790.28	1,138.49
Total Shareholder's Fund	329.14	325.65	415.09	508.17	892.73

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	37.27	-10.74	-52.69	38.27	-82.86
Net Cash used in Investing Activities	-51.01	2.41	39.54	-37.32	-16.58
Net Cash used in Financing Activities	12.82	9.01	9.83	-7.20	109.39

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	147.35	115.72	136.46	150.50	143.02
Total Expenses	140.35	129.71	142.50	150.65	146.58
Profit Before Tax	4.76	-17.05	-2.12	-1.65	-7.78
Profit After Tax	4.71	-15.88	-1.99	-2.20	-8.29
Operating Profit after Depreciation	11.65	-10.19	4.77	5.53	-0.33

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	76.64	56.88	80.37	95.23	94.59
Total Expenses	69.90	67.37	89.61	88.59	84.63
Profit Before Tax	1.30	-14.98	-1.35	1.07	3.20
Profit After Tax	1.29	-13.78	-1.37	0.43	3.20
Operating Profit after Depreciation	10.15	-6.69	7.15	9.69	12.09

Panacea Biotec Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 316.88

S2 308.42

S3 300.83

Pivot 324.47

R1 332.93

R2 340.52

R3 348.98

Moving Average

20 SMA 404.62

50 SMA 427.20

100 SMA 374.80

200 SMA 262.52

Panacea Biotec Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

No available data

AGM Date: 28 Sep 2022

The Board of Directors of the Company has, at its meeting held on 09.08.2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) for the quarter ended June 30, 2022. The same were also reviewed by the Audit Committee in its meeting held earlier on 09.08.2022. We wish to further inform you that the Board of Directors has also decided that: i) the 38th AGM of the Company will be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / Other Audio-Visual Means; and ii) the Register of Members and Share Transfer Books will remain closed from Wednesday, 21.09.2022 to Wednesday, 28.09.2022 (both days inclusive) for the purpose of AGM. The meeting of the Board of Directors commenced at 12:30 P.M. and concluded at 3:15 P.M. We would like to inform you that 38th AGM of the Company is to be held on Wednesday, 28.09.2022 at 11:30 A.M. through VC / OAVM. A copy of Notice of AGM along with Annual Report for FY 2021-22 sent to the shareholders through email is enclosed herewith for your reference. Also, the Company is pleased to provide remote e-voting facility to its members to cast their votes electronically on all resolutions set forth in enclosed AGM Notice. Further, relating to AGM of the Company, you are requested to take note of the following: 1. Register of Members and Share Transfer Books shall remain closed from 21.09.2022 to 28.09.2022 (both days inclusive). 2. The cut-off date for remote e-voting, shall be 21.09.2022. 3. The remote e-voting period shall commence on 25.09. 2022 (from 09:00 a.m. IST) and end on 27.09.2022 (upto 05:00 p.m. IST). Remote e-Voting facility will also be available during the AGM for the members attending the AGM. This is for your kind information and record please. (As Per BSE Announcement Dated on 06.09.2022) Please find enclosed herewith proceedings of 38th Annual General Meeting ('AGM') of the Company held on Wednesday, September 28, 2022 at 11:30 A.M. through Video Conferencing ('VC'). The detailed voting results of all the businesses transacted at the AGM as set out in the AGM Notice along with the consolidated Scrutinizer's Report as required under Regulation 44 of the SEBI LODR Regulations shall be submitted in due course of time Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the detailed voting results along with the Scrutinizer's Report is enclosed herewith. (As Per BSE Announcement Dated on 29/09/2022)

AGM Date: 29 Sep 2023

AGM 29/09/2023 We would like to inform you that the 39th Annual General Meeting of the Company is scheduled to be held on Friday, 29.09.2023 at 11:30 A.M. through VC / OAVM. We are submitting herewith the Annual Report for the financial year 2022-23 including AGM notice, which is being sent to the members through electronic mode. The cut-off date for the purpose of exercising remote e-voting shall be Friday, 22.09.2023 (As Per BSE Announcement dated on 07.09.2023) Please find enclosed herewith the proceedings of the 39th Annual General Meeting of the Company held on Friday, September 29, 2023 at 11:30 A.M. through video Conferencing. (As Per BSE Announcement dated on 29.09.2023) The detailed voting results along with Scrutinizer''s Report for the Annual General Meeting held on September 29, 2023 is enclosed herewith. (As per BSE Announcement Dated on 30/09/2023)

AGM Date: 27 Sep 2024

AGM 27/09/2024 Please find enclosed Annual Report of Panacea Biotec Ltd. for financial year 2023-24. (As Per Bse Announcement Dated on 05.09.2024) We would like to inform you that the shareholders of the Company in their 40th AGM held today i.e. Friday, September 27, 2024, inter-alia approved the appointment of M/s Suresh Surana & Associates LLP, Chartered Accountants as Statutory Auditors of the Company for a period of 5 consecutive years to hold office from the conclusion of 40th AGM till the conclusion of 45th AGM of the Company in place of retiring auditors, M/s Walker Chandiok & Co. LLP, Chartered Accountants. (As Per BSE Announcement dated on 27.09.2024) The detailed voting results along with Scrutinizer''s report for the AGM held on September 27, 2024 of the Company is enclosed herewith (As Per BSE Announcement dated on 28.09.2024)

EGM Date: 26 Feb 2022

We would like to state that an EGM of the Company is scheduled to be held on Saturday, February 26, 2022 at 11:30 A.M. through VC / OAVM in terms of the Circulars issued by the Ministry of Corporate Affairs and SEBI from time to time. Further, relating to the EGM of the Company, you are requested to take note of the following: 1. For the purpose of exercising remote e-voting, the cut-off date shall be Saturday, February 19, 2022. 2. The remote e-voting period shall commence on Wednesday, February 23, 2022 (from 09:00 a.m. IST) and end on Friday, September 25, 2022 (upto 05:00 p.m. IST). 3. Remote e-Voting facility will also be available during the EGM for the members attending the EGM. In regard to the above, a copy of Notice of the EGM being sent to the shareholders through email is enclosed herewith for your reference. Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations'), please find enclosed herewith the proceedings of the Extraordinary General Meeting ('EGM') of the Company held on Saturday, February 26, 2022 at 11 :30 A.M. through Video Conferencing ('VC'). The detailed voting results of the business transacted at the EGM as set out in the EGM Notice along with the consolidated Scrutinizer''s Report as required under Regulation 44 of the SEBI LODR Regulations shall be submitted in due course of time. This is for your information and record please. This is in continuation of our earlier letter dated February 26, 2022 along with Proceedings of the Extraordinary General Meeting of the Company held on February 26, 2022 and also informing that the detailed voting results of the business transacted at the EGM, as required under Regulation 44 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations') shall be submitted to you upon receipt of Scrutinizer''s Report. We would like to inform you that as per the Scrutinizer''s Report, the resolution mentioned in the EGM notice has been passed by the shareholders with requisite majority. Pursuant to Regulation 44(3) of the SEBI LODR Regulations read with amended Rule 20 of Companies (Management and Administration) Rules, 2015, the detailed voting results along with the Scrutinizer''s Report is enclosed herewith. This is for your information and record. Kindly acknowledge the receipt. Panacea Biotec Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. (As Per BSE Announcement Dated on 26/02/2022)

Panacea Biotec Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Panacea Biotec Ltd	₹324.90	₹1,990.04
Sun Pharmaceuticals Industries Ltd	₹1,745.25	₹4,18,743.94
Divis Laboratories Ltd	₹5,733.60	₹1,52,209.07
Cipla Ltd	₹1,458.15	₹1,17,762.24
Torrent Pharmaceuticals Ltd	₹3,357.15	₹1,13,616.11
Mankind Pharma Ltd	₹2,488.40	₹1,02,663.15

Panacea Biotec Ltd News

Panacea Biotec Pharma launches 'NikoMom' brand of baby diapers and wipes

03 Jan 2025, 03:24 pm

Panacea Biotec announces investment in Panacea Biotec Inc.

28 Dec 2024, 02:00 pm

Panacea Biotec hits the roof on bagging order worth Rs 127-cr from UNICEF

Panacea Biotec hit an upper circuit of 5% at Rs 455.70 after the company received a letter of award (LoA) from the United Nations International Children's Emergency Fund (UNICEF) for supply its bivalent oral polio vaccine (bOPV).

26 Dec 2024, 10:30 am

Panacea Biotec wins order of Rs 127 cr from UNICEF

24 Dec 2024, 05:54 pm

Panacea Biotec to hold board meeting

On 13 November 2024

31 Oct 2024, 12:09 pm

Panacea Biotec Ltd Stock Analysis

Annual revenue for Panacea Biotec Ltd increased by 31.91% to ₹384.51 crore in FY 2024 from ₹291.50 crore in FY 2023.
Annual Net Profit for Panacea Biotec Ltd decreased by 104.06% to ₹3.55 crore in FY 2024 from ₹-87.54 crore in FY 2023.
Promoter Shareholding in Panacea Biotec Ltd decreased by 0.52% in the most recent quarter, from 72.87% in September 2024 to 72.49% in December 2024.
Panacea Biotec Ltd delivered a 1-year return of 98.93% compared to the Nifty 50, which provided a return of 8.03% as of the last trading session.
Panacea Biotec Ltd share price moved up by 4.99% from its previous close of INR ₹325.35. The latest Panacea Biotec Ltd share price is INR ₹341.60.
Panacea Biotec Ltd share price today has been at a low of 322.25 and a high of 341.60. Over the past 52 weeks, the Panacea Biotec Ltd share price has seen a low of 112.35 and a high of 490.55.